TrialJournal of gastroenterology and hepatology2021

Seraprevir and sofosbuvir for treatment of chronic hepatitis C virus infection: A single-arm, open-label, phase 3 trial.

Fei Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.